Klaria Pharma (Sweden) Buy Hold or Sell Recommendation

KLAR Stock  SEK 1.14  0.11  10.68%   
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Klaria Pharma Holding is 'Cautious Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Klaria Pharma Holding given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Klaria Pharma Holding, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Klaria Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
Note, we conduct extensive research on individual companies such as Klaria and provide practical buy, sell, or hold advice based on investors' constraints. Klaria Pharma Holding. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Execute Klaria Pharma Buy or Sell Advice

The Klaria recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Klaria Pharma Holding. Macroaxis does not own or have any residual interests in Klaria Pharma Holding or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Klaria Pharma's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Klaria PharmaBuy Klaria Pharma
Cautious Hold

Market Performance

GoodDetails

Volatility

Out of controlDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Barely shadows the marketDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

InapplicableDetails
For the selected time horizon Klaria Pharma Holding has a Mean Deviation of 9.44, Semi Deviation of 6.5, Standard Deviation of 17.77, Variance of 315.88, Downside Variance of 59.26 and Semi Variance of 42.2
We provide investment recommendation to complement the last-minute expert consensus on Klaria Pharma Holding. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the entity's potential to grow using all technical and fundamental data available at the time. To make sure Klaria Pharma Holding is not overpriced, please verify all Klaria Pharma Holding fundamentals, including its shares outstanding, shares owned by institutions, and the relationship between the current valuation and shares owned by insiders .

Klaria Pharma Trading Alerts and Improvement Suggestions

Klaria Pharma is way too risky over 90 days horizon
Klaria Pharma may become a speculative penny stock
Klaria Pharma appears to be risky and price may revert if volatility continues
Klaria Pharma Holding has accumulated 1.02 M in total debt. Klaria Pharma Holding has a current ratio of 0.67, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Klaria Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Klaria Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Klaria Pharma Holding sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Klaria to invest in growth at high rates of return. When we think about Klaria Pharma's use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (53.53 M) with profit before overhead, payroll, taxes, and interest of 5.87 M.
Klaria Pharma Holding has accumulated about 25.49 M in cash with (24.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.47.

Klaria Pharma Returns Distribution Density

The distribution of Klaria Pharma's historical returns is an attempt to chart the uncertainty of Klaria Pharma's future price movements. The chart of the probability distribution of Klaria Pharma daily returns describes the distribution of returns around its average expected value. We use Klaria Pharma Holding price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Klaria Pharma returns is essential to provide solid investment advice for Klaria Pharma.
Mean Return
2.65
Value At Risk
-10.43
Potential Upside
21.33
Standard Deviation
17.77
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Klaria Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Klaria Pharma Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Klaria Pharma or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Klaria Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Klaria stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
3.04
β
Beta against Dow Jones3.67
σ
Overall volatility
18.38
Ir
Information ratio 0.15

Klaria Pharma Volatility Alert

Klaria Pharma Holding is displaying above-average volatility over the selected time horizon. Klaria Pharma Holding is a potential penny stock. Although Klaria Pharma may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Klaria Pharma Holding. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Klaria instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

Klaria Pharma Fundamentals Vs Peers

Comparing Klaria Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Klaria Pharma's direct or indirect competition across all of the common fundamentals between Klaria Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Klaria Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Klaria Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Klaria Pharma by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Klaria Pharma to competition
FundamentalsKlaria PharmaPeer Average
Return On Equity-0.88-0.31
Return On Asset-0.29-0.14
Operating Margin(9.48) %(5.51) %
Current Valuation88.14 M16.62 B
Shares Outstanding63.1 M571.82 M
Shares Owned By Insiders10.73 %10.09 %
Shares Owned By Institutions9.75 %39.21 %
Price To Earning(18.43) X28.72 X
Price To Book1.42 X9.51 X
Price To Sales8.00 X11.42 X
Gross Profit5.87 M27.38 B
EBITDA(39.41 M)3.9 B
Net Income(53.53 M)570.98 M
Cash And Equivalents25.49 M2.7 B
Cash Per Share0.47 X5.01 X
Total Debt1.02 M5.32 B
Current Ratio0.68 X2.16 X
Book Value Per Share0.97 X1.93 K
Cash Flow From Operations(24.8 M)971.22 M
Earnings Per Share(1.72) X3.12 X
Number Of Employees618.84 K
Beta0.39-0.15
Market Capitalization39.49 M19.03 B
Total Asset118.31 M29.47 B
Retained Earnings(9 M)9.33 B
Working Capital41 M1.48 B
Current Asset44 M9.34 B
Current Liabilities3 M7.9 B
Z Score22.88.72
Net Asset118.31 M

Klaria Pharma Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Klaria . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Klaria Pharma Buy or Sell Advice

When is the right time to buy or sell Klaria Pharma Holding? Buying financial instruments such as Klaria Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Klaria Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Volatility ETFs Thematic Idea Now

Volatility ETFs
Volatility ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Volatility ETFs theme has 26 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Volatility ETFs Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Klaria Stock Analysis

When running Klaria Pharma's price analysis, check to measure Klaria Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Klaria Pharma is operating at the current time. Most of Klaria Pharma's value examination focuses on studying past and present price action to predict the probability of Klaria Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Klaria Pharma's price. Additionally, you may evaluate how the addition of Klaria Pharma to your portfolios can decrease your overall portfolio volatility.